Related Experiment Video
Updated: Jun 3, 2026

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
Published on: November 10, 2017
Do statins reduce the incidence of stroke in familial hypercholesterolemia?
Alpo F Vuorio1, Petri T Kovanen
1Mehiläinen Airport Medical Center, Vantaa, Finland. alpo.vuorio@welho.com
Insights
Familial hypercholesterolemia (FH) significantly increases stroke risk due to high LDL-cholesterol. Statin treatments effectively lower LDL-cholesterol, reducing ischemic stroke incidence in FH patients.
Area of Science:
- Cardiovascular Medicine
- Neurology
- Genetics
Background:
- Familial hypercholesterolemia (FH) is a genetic disorder characterized by lifelong elevated serum LDL-cholesterol.
- Untreated FH substantially increases the risk of coronary and carotid artery atherosclerosis, leading to premature myocardial infarction and ischemic brain infarction.
- Historically, stroke incidence in FH patients was significantly higher than in the general population.
Purpose of the Study:
- To investigate the impact of statin treatment on ischemic stroke incidence in patients with Familial hypercholesterolemia.
- To evaluate the role of LDL-cholesterol lowering in mitigating cerebrovascular risk in FH.
Main Methods:
- Review of registry and MRI studies examining ischemic brain damage in FH patients during the statin era.
- Analysis of meta-analyses of controlled statin trials.
Main Results:
- In the statin era, studies suggest that the occurrence of ischemic brain damage is not increased among FH patients.
- Effective lowering of serum LDL-cholesterol through statin therapy is associated with a decreased incidence of ischemic stroke.
- A meta-analysis confirmed that statin treatment reduces ischemic stroke incidence in hypercholesterolemic patients, including those without FH.
Conclusions:
- Statin therapy plays a crucial role in reducing the risk of ischemic stroke in patients with Familial hypercholesterolemia.
- Aggressive LDL-cholesterol lowering is a key strategy for preventing cerebrovascular events in FH.
- The findings underscore the importance of early diagnosis and treatment of FH to prevent cardiovascular and cerebrovascular complications.
Abstract:
Familial hypercholesterolemia (FH) causes lifelong elevated serum LDL-cholesterol. In untreated FH, the progression of coronary atherosclerosis and the risk of premature myocardial infarction are substantially increased. In addition, carotid artery atherosclerosis and the risk of ischemic brain infarction are increased. During the prestatin era, stroke may have been even 20-times more frequent among FH patients than in the general population. In the statin era, both registry studies and MRI studies suggest that the occurrence of ischemic brain damage is not increased among FH patients. It is likely that effective lowering of serum LDL-cholesterol levels made possible by statin treatment has been the key element behind the observed decrease in of the incidence of ischemic stroke. This idea is strongly supported by the results of a recent meta-analysis of controlled statin trials, in which statin treatment was demonstrated to lower the incidence of ischemic stroke among non-FH hypercholesterolemic patients.
Related Concept Videos
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Atherosclerosis III: Management
Cholesterol: Significance and Regulation
Considering cholesterol and...
Coronary Artery Disease IV: Preventive Measures
Pharmacogenomics: Identification of New Drug Targets
Atherosclerosis IV: Nursing Management
